Warriors C Andrew Bogut undergoes PRP therapy on knee, out indefinitely
Golden State Warriors center Andrew Bogut is out indefinitely after undergoing platelet-rich plasma therapy on his right knee, the team announced Thursday.
The Warriors also revealed Bogut's condition to be knee chondromalacia and bone edema, which was determined from a Dec. 10 MRI.
"We fully support Andrew in his decision to undergo the PRP treatment,” Warriors General Manager Bob Myers said in a statement. “Our number one concern is that Andrew is 100% healthy and we will continue to support him in any way we can to make that happen.”
• MAHONEY: Rondo a fascinating possibility for Mavericks
Bogut's knee issues originated in the Warriors' game against the Minnesota Timberwolves on Dec. 8, which the Australian was forced to leave early. Thursday night's game against the Oklahoma City Thunder will be the fifth that Bogut has missed so far.
The team initially listed Bogut's injury as knee tendinitis. He had the knee drained last Friday and hoped to return this week before ultimately electing to have the PRP therapy.
Bogut's agent, David Bauman, told the Bay Area News Group that Bogut's situation is similar to that of Houston Rockets center Dwight Howard, who missed three weeks after also undergoing PRP therapy on his knee.
"Thank God it's nothing major," said Bauman, whose Relativity Sports agency also represents Howard. "It's a temporary setback.
"I'm not going to say two, three, four weeks, but that's probably a reasonable assumption if all goes well, and then he'll return sometime in January."
• GOLLIVER: What Parker's knee injury means for Bucks
Bogut has a history of injury issues. Since joining Golden State two seasons ago, he missed 50 games in the 2012-13 season after undergoing ankle surgery and missed the Warriors' first-round playoff loss to the Los Angeles Clippers last year due to a fractured rib.
The Warriors, who had their franchise-record 16-game winning streak snapped by the Memphis Grizzlies on Tuesday, have the NBA's best record at 21-3.
- Ben Estes
